By: Kairos Ventures On: January 29, 2018 In: Portfolio News, Sienza Energy

We are thrilled that Sienza Energy is the latest company to join the Kairos portfolio. Sienza Energy is a...

Read more
By: Kairos Ventures On: January 3, 2018 In: Portfolio News, Symbiotix

We are pleased to announce that our portfolio company Symbiotix has entered into a process development and manufacturing agreement...

Read more

Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...

Read more
By: Kairos Ventures On: November 6, 2017 In: Portfolio News, Provivi

We are pleased to announce that our portfolio company Provivi, Inc. closed on the first $21 million of a...

Read more
By: Kairos Ventures On: November 1, 2017 In: Portfolio News, Symbiotix

We are pleased to announce that Symbiotix Biotherapies, Inc. is the latest company to join the Kairos portfolio. Founded in...

Read more
By: Kairos Ventures On: October 8, 2017 In: MixComm, Portfolio News

We are delighted to announce that MixComm Inc. is the latest company to join the Kairos portfolio. MixComm Inc....

Read more

Founded in 2017 Opera Therapeutics is a biopharmaceutical company that is developing next-generation treatments for ocular and neurological diseases.

Read more
By: Kairos Ventures On: September 29, 2017 In: Auspion, Portfolio News

We are thrilled to announce that Auspion Inc. has joined the Kairos Portfolio. Auspion, Inc. is a wireless communications...

Read more

We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...

Read more

We are delighted to announce that Chimera Bioengineering is the latest company to join the Kairos portfolio. Founded in...

Read more